DONs modified with TNF-related apoptosis-inducing ligands can promote apoptosis of human breast cancer cells, providing a new strategy for ineffective TNF superfamily activation methods based on ligands and antibodies (Wang et al., 2021a). Here, TNF is linked to breast cancer.